336 related articles for article (PubMed ID: 23250913)
1. mTOR dysfunction contributes to vacuolar pathology and weakness in valosin-containing protein associated inclusion body myopathy.
Ching JK; Elizabeth SV; Ju JS; Lusk C; Pittman SK; Weihl CC
Hum Mol Genet; 2013 Mar; 22(6):1167-79. PubMed ID: 23250913
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin-induced autophagy aggravates pathology and weakness in a mouse model of VCP-associated myopathy.
Ching JK; Weihl CC
Autophagy; 2013 May; 9(5):799-800. PubMed ID: 23439279
[TBL] [Abstract][Full Text] [Related]
3. Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease.
Ju JS; Fuentealba RA; Miller SE; Jackson E; Piwnica-Worms D; Baloh RH; Weihl CC
J Cell Biol; 2009 Dec; 187(6):875-88. PubMed ID: 20008565
[TBL] [Abstract][Full Text] [Related]
4. Transgenic expression of inclusion body myopathy associated mutant p97/VCP causes weakness and ubiquitinated protein inclusions in mice.
Weihl CC; Miller SE; Hanson PI; Pestronk A
Hum Mol Genet; 2007 Apr; 16(8):919-28. PubMed ID: 17329348
[TBL] [Abstract][Full Text] [Related]
5. Valosin-containing protein disease: inclusion body myopathy with Paget's disease of the bone and fronto-temporal dementia.
Weihl CC; Pestronk A; Kimonis VE
Neuromuscul Disord; 2009 May; 19(5):308-15. PubMed ID: 19380227
[TBL] [Abstract][Full Text] [Related]
6. Valosin containing protein associated fronto-temporal lobar degeneration: clinical presentation, pathologic features and pathogenesis.
Weihl CC
Curr Alzheimer Res; 2011 May; 8(3):252-60. PubMed ID: 21222596
[TBL] [Abstract][Full Text] [Related]
7. The multiple faces of valosin-containing protein-associated diseases: inclusion body myopathy with Paget's disease of bone, frontotemporal dementia, and amyotrophic lateral sclerosis.
Nalbandian A; Donkervoort S; Dec E; Badadani M; Katheria V; Rana P; Nguyen C; Mukherjee J; Caiozzo V; Martin B; Watts GD; Vesa J; Smith C; Kimonis VE
J Mol Neurosci; 2011 Nov; 45(3):522-31. PubMed ID: 21892620
[TBL] [Abstract][Full Text] [Related]
8. VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD.
Tresse E; Salomons FA; Vesa J; Bott LC; Kimonis V; Yao TP; Dantuma NP; Taylor JP
Autophagy; 2010 Feb; 6(2):217-27. PubMed ID: 20104022
[TBL] [Abstract][Full Text] [Related]
9. The homozygote VCP(R¹⁵⁵H/R¹⁵⁵H) mouse model exhibits accelerated human VCP-associated disease pathology.
Nalbandian A; Llewellyn KJ; Kitazawa M; Yin HZ; Badadani M; Khanlou N; Edwards R; Nguyen C; Mukherjee J; Mozaffar T; Watts G; Weiss J; Kimonis VE
PLoS One; 2012; 7(9):e46308. PubMed ID: 23029473
[TBL] [Abstract][Full Text] [Related]
10. Valosin containing protein associated inclusion body myopathy: abnormal vacuolization, autophagy and cell fusion in myoblasts.
Vesa J; Su H; Watts GD; Krause S; Walter MC; Martin B; Smith C; Wallace DC; Kimonis VE
Neuromuscul Disord; 2009 Nov; 19(11):766-72. PubMed ID: 19828315
[TBL] [Abstract][Full Text] [Related]
11. Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone.
Custer SK; Neumann M; Lu H; Wright AC; Taylor JP
Hum Mol Genet; 2010 May; 19(9):1741-55. PubMed ID: 20147319
[TBL] [Abstract][Full Text] [Related]
12. Inclusion body myopathy, Paget's disease of the bone and fronto-temporal dementia: a disorder of autophagy.
Ju JS; Weihl CC
Hum Mol Genet; 2010 Apr; 19(R1):R38-45. PubMed ID: 20410287
[TBL] [Abstract][Full Text] [Related]
13. A progressive translational mouse model of human valosin-containing protein disease: the VCP(R155H/+) mouse.
Nalbandian A; Llewellyn KJ; Badadani M; Yin HZ; Nguyen C; Katheria V; Watts G; Mukherjee J; Vesa J; Caiozzo V; Mozaffar T; Weiss JH; Kimonis VE
Muscle Nerve; 2013 Feb; 47(2):260-70. PubMed ID: 23169451
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9-Mediated Constitutive Loss of VCP (Valosin-Containing Protein) Impairs Proteostasis and Leads to Defective Striated Muscle Structure and Function In Vivo.
Voisard P; Diofano F; Glazier AA; Rottbauer W; Just S
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743185
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the Asian myopathy patients with VCP mutations.
Shi Z; Hayashi YK; Mitsuhashi S; Goto K; Kaneda D; Choi YC; Toyoda C; Hieda S; Kamiyama T; Sato H; Wada M; Noguchi S; Nonaka I; Nishino I
Eur J Neurol; 2012 Mar; 19(3):501-9. PubMed ID: 22040362
[TBL] [Abstract][Full Text] [Related]
16. Nuclear localization of valosin-containing protein in normal muscle and muscle affected by inclusion-body myositis.
Greenberg SA; Watts GD; Kimonis VE; Amato AA; Pinkus JL
Muscle Nerve; 2007 Oct; 36(4):447-54. PubMed ID: 17626287
[TBL] [Abstract][Full Text] [Related]
17. VCP maintains lysosomal homeostasis and TFEB activity in differentiated skeletal muscle.
Arhzaouy K; Papadopoulos C; Schulze N; Pittman SK; Meyer H; Weihl CC
Autophagy; 2019 Jun; 15(6):1082-1099. PubMed ID: 30654731
[TBL] [Abstract][Full Text] [Related]
18. IBMPFD Disease-Causing Mutant VCP/p97 Proteins Are Targets of Autophagic-Lysosomal Degradation.
Bayraktar O; Oral O; Kocaturk NM; Akkoc Y; Eberhart K; Kosar A; Gozuacik D
PLoS One; 2016; 11(10):e0164864. PubMed ID: 27768726
[TBL] [Abstract][Full Text] [Related]
19. Pathogenic VCP/TER94 alleles are dominant actives and contribute to neurodegeneration by altering cellular ATP level in a Drosophila IBMPFD model.
Chang YC; Hung WT; Chang YC; Chang HC; Wu CL; Chiang AS; Jackson GR; Sang TK
PLoS Genet; 2011 Feb; 7(2):e1001288. PubMed ID: 21304887
[TBL] [Abstract][Full Text] [Related]
20. Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation.
Weihl CC; Dalal S; Pestronk A; Hanson PI
Hum Mol Genet; 2006 Jan; 15(2):189-99. PubMed ID: 16321991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
